# ASPIRIN Trial Belgium

Source: https://onco.cc/trials/nct03464305/  
OnCo record `nct03464305` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of aspirin in colorectal cancer, run by University Hospital, Antwerp, active but no longer recruiting.

## Summary

ASPIRIN Trial Belgium is a phase 3, randomised interventional study registered as NCT03464305 by University Hospital, Antwerp, with a registry enrolment figure of 148 participants, started 2018-02-22 and due to reach its primary completion in 2027-12-31. Interventions recorded: acetylsalicylic acid; Placebo. Conditions listed: Colon Cancer. Primary outcome: 5 year overall survival. Colorectal eligibility wording from the registry: "* Patients 45 years and older with histologically confirmed adenocarcinoma of the colon". Sites: Belgium. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-24
- Also known as: ASPIRIN
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT03464305
- Phase: 3
- Setting: A Phase III Double-blind Placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients
- Sponsor: University Hospital, Antwerp
- Enrolled: 148

## Sources

- ClinicalTrials.gov NCT03464305: https://clinicaltrials.gov/study/NCT03464305

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/)
- drugs: [Aspirin](https://onco.cc/drugs/aspirin/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct03464305.json